Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA – Get Free Report) saw a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 65,700 shares, a growth of 247.6% from the October 15th total of 18,900 shares. Currently, 1.1% of the shares of the stock are short sold. Based […]